These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Hydroxypropyl-beta-cyclodextrin-mediated efflux of 7-ketocholesterol from macrophage foam cells. Kritharides L; Kus M; Brown AJ; Jessup W; Dean RT J Biol Chem; 1996 Nov; 271(44):27450-5. PubMed ID: 8910326 [TBL] [Abstract][Full Text] [Related]
6. Mechanistic studies of the effect of hydroxypropyl-beta-cyclodextrin on in vitro transdermal permeation of corticosterone through hairless mouse skin. Shaker DS; Ghanem AH; Li SK; Warner KS; Hashem FM; Higuchi WI Int J Pharm; 2003 Mar; 253(1-2):1-11. PubMed ID: 12593932 [TBL] [Abstract][Full Text] [Related]
7. Cyclodextrin-mediated conjugation of macrophage and liposomes for treatment of atherosclerosis. Gao C; Liu C; Chen Q; Wang Y; Kwong CHT; Wang Q; Xie B; Lee SMY; Wang R J Control Release; 2022 Sep; 349():2-15. PubMed ID: 35779655 [TBL] [Abstract][Full Text] [Related]
8. Cyclodextrins and Iatrogenic Hearing Loss: New Drugs with Significant Risk. Crumling MA; King KA; Duncan RK Front Cell Neurosci; 2017; 11():355. PubMed ID: 29163061 [TBL] [Abstract][Full Text] [Related]
12. Differential Effects of 2-Hydroxypropyl-Cyclodextrins on Lipid Accumulation in Hoque S; Kondo Y; Sakata N; Yamada Y; Fukaura M; Higashi T; Motoyama K; Arima H; Higaki K; Hayashi A; Komiya T; Ishitsuka Y; Irie T Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019132 [TBL] [Abstract][Full Text] [Related]
13. Alpha-cyclodextrin inhibits cholesterol crystal-induced complement-mediated inflammation: A potential new compound for treatment of atherosclerosis. Pilely K; Bakke SS; Palarasah Y; Skjoedt MO; Bartels ED; Espevik T; Garred P Atherosclerosis; 2019 Apr; 283():35-42. PubMed ID: 30772772 [TBL] [Abstract][Full Text] [Related]
14. Interaction of iodine with 2-hydroxypropyl-alpha-cyclodextrin and its bactericidal activity. Tomono K; Goto H; Suzuki T; Ueda H; Nagai T; Watanabe J Drug Dev Ind Pharm; 2002 Nov; 28(10):1303-9. PubMed ID: 12476876 [TBL] [Abstract][Full Text] [Related]
15. Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-beta-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery. McCormack B; Gregoriadis G Biochim Biophys Acta; 1996 Dec; 1291(3):237-44. PubMed ID: 8980638 [TBL] [Abstract][Full Text] [Related]
16. Changes in membrane biophysical properties induced by the Budesonide/Hydroxypropyl-β-cyclodextrin complex. Dos Santos AG; Bayiha JC; Dufour G; Cataldo D; Evrard B; Silva LC; Deleu M; Mingeot-Leclercq MP Biochim Biophys Acta Biomembr; 2017 Oct; 1859(10):1930-1940. PubMed ID: 28642042 [TBL] [Abstract][Full Text] [Related]
17. Hearing loss and hair cell death in mice given the cholesterol-chelating agent hydroxypropyl-β-cyclodextrin. Crumling MA; Liu L; Thomas PV; Benson J; Kanicki A; Kabara L; Hälsey K; Dolan D; Duncan RK PLoS One; 2012; 7(12):e53280. PubMed ID: 23285273 [TBL] [Abstract][Full Text] [Related]
18. Interaction of [D-Trp6, Des-Gly10] LHRH ethylamide and hydroxy propyl beta-cyclodextrin (HPbetaCD): thermodynamics of interaction and protection from degradation by alpha-chymotrypsin. Koushik KN; Bandi N; Kompella UB Pharm Dev Technol; 2001 Nov; 6(4):595-606. PubMed ID: 11775960 [TBL] [Abstract][Full Text] [Related]
19. Preclinical Reversal of Atherosclerosis by FDA-Approved Compound that Transforms Cholesterol into an Anti-Inflammatory "Prodrug". Mendelsohn AR; Larrick JW Rejuvenation Res; 2016 Jun; 19(3):252-5. PubMed ID: 27241174 [TBL] [Abstract][Full Text] [Related]
20. Safety of oral cyclodextrins: effects of hydroxypropyl cyclodextrins, cyclodextrin sulfates and cationic cyclodextrins on steroid balance in rats. Gerloczy A; Hoshino T; Pitha J J Pharm Sci; 1994 Feb; 83(2):193-6. PubMed ID: 8169787 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]